Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
79 Leser
Artikel bewerten:
(0)

Sono Bello Appoints Michael Gellis, MD as Chief Medical Officer

SEATTLE, Feb. 1, 2012 /PRNewswire/ -- Sono Bello, a growing multi-state medical practice, has appointed Michael Gellis, MD as Chief Medical Officer. In this role, Dr. Gellis will provide clinical leadership to the company, which exclusively performs laser-assisted liposuction in office-based centers with 12 locations in 9 states.The appointment of Dr. Gellis as CMO (Chief Medical Officer) continues Sono Bello's efforts to elevate the quality of medical care provided in their centers.

(Photo: http://photos.prnewswire.com/prnh/20120201/LA46109)

Dr. Gellis graduated from Wayne State University medical school followed by training in general surgery. He completed his plastic surgery residency in 1976 at Beaumont Hospital. He has a lifetime certification with the American Board of Plastic Surgery. Dr. Gellis is an accomplished clinician and served as the Chairman of the Division of Plastic Surgery at Beaumont Hospital for 11 years where he managed the activities of 26 plastic surgeons and countless residents. Dr. Gellis has many areas of special interest including liposuction for which he has developed an FDA approved device.

Dr. Gellis will be involved in appointing new physician hires, proctoring current physicians and assisting with further development of the professional services for Sono Bello. He will work closely with major plastic and cosmetic medical societies on behalf of Sono Bello to share the organizations knowledge and experience. He will spearhead the Education and Standards committee, which is responsible for education and research to include presentations and publications. As such he will further develop standards of practice to which all physicians associated with Sono Bello adhere. The underlying goal is to provide the same level of excellence regardless of which Sono Bello facility or which surgeon is utilized.

Sono Bello has over 35 trained surgeons most of whom are recognized by the American Society of Plastic Surgeons. Dr. Gellis will take the helm of this superb group to provide additional leadership and oversight. With his supervision Sono Bello will continue to set the standards for minimally invasive laser liposuction. Dr. Gellis will promote patient safety, excellent surgical outcomes and adherence to the high practice standards expected by our patients.

Sono Bello has been performing awake laser assisted liposuction for over 3 years. During that time some 17,000 surgeries have been performed. Review of complications and other standard measures indicate that Sono Bello is meeting the high expectations demanded in plastic surgery. Sono Bello clinics are accredited by the Accreditation Association for Ambulatory Health Care (AAAHC) which is an independent not-for-profit organization accrediting outstanding medical practices. This is an optional process confirming that Sono Bello meets the highest recognized standards in patient safety and quality of care. Most authorities recommend plastic surgery be obtained only at an accredited facility.

Dr. Gellis is a welcome addition and further proof of the dedication Sono Bello has to their patients and the medical community. Significant growth is anticipated in 2012 and Dr. Gellis will ensure that this is done in a manner that promotes patient safety and continues Sono Bello's tradition of excellence.

We are pleased to announce Dr. Michael Gellis as Chief Medical Officer of Sono Bello.

For further details or to arrange an interview, please email; news@sonobello.com or call Sono Bello at 1.877.766.6235.

SOURCESono Bello

© 2012 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.